{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T09:55:27Z","timestamp":1767347727669,"version":"3.48.0"},"reference-count":46,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T00:00:00Z","timestamp":1767312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: Febrile neutropenia (FN) is a potentially life-threatening complication in children undergoing cancer treatment. Immediate initiation of empirical antibiotic treatment (EAT) has improved the prognosis and outcomes of FN. Although the ideal timing for initiating EAT is clear, the optimal timing for EAT discontinuation remains debatable. Early hospital discharge (EHD) with continuation of oral antibiotics has also been proposed as an alternative strategy. This narrative review aims to present a comprehensive overview of the evidence on early discontinuation of EAT or EHD in children with FN and cancer. Materials and Methods: A comprehensive literature search was performed to identify relevant studies assessing early EAT discontinuation or EHD in children with cancer and FN. Extracted data included the safety outcomes, the benefits for the patients and the cost for healthcare systems. Results: Thirty-one studies were included; twenty-one investigated the early discontinuation of EAT and ten studies evaluated EHD. Most studies reported early discontinuation of EAT or EHD as a safe FN treatment approach with potential benefits for the patients, especially when applied to selected low-risk FN cases. Reported benefits included shorter hospitalization duration and reduced antibiotic use, with additional economic advantages in several studies. Conclusions: Early discontinuation of EAT appears to be a safe and beneficial management approach for children with FN and cancer by reducing the length of hospital stay and the duration of antibiotic use. EHD with oral therapy continuation also appears to be safe but less beneficial than early discontinuation of EAT. High-quality evidence and standardized criteria are needed to support broader implementation of these strategies in routine clinical practice.<\/jats:p>","DOI":"10.3390\/medicina62010103","type":"journal-article","created":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T09:18:56Z","timestamp":1767345536000},"page":"103","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Early Discontinuation of Empiric Antibiotic Therapy in Children with Cancer and Febrile Neutropenia: A Narrative Review"],"prefix":"10.3390","volume":"62","author":[{"given":"Smaragda","family":"Papachristidou","sequence":"first","affiliation":[{"name":"Second Department of Paediatrics, School of Medicine, National and Kapodistrian University of Athens (NKUA), P.&A. Kyriakou Children\u2019s Hospital, 11527 Athens, Greece"},{"name":"Department of Paediatric Oncology, P.&A. Kyriakou Children\u2019s Hospital, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4470-263X","authenticated-orcid":false,"given":"Dimitra","family":"Dimopoulou","sequence":"additional","affiliation":[{"name":"Second Department of Paediatrics, School of Medicine, National and Kapodistrian University of Athens (NKUA), P.&A. Kyriakou Children\u2019s Hospital, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3553-8893","authenticated-orcid":false,"given":"George","family":"Pantalos","sequence":"additional","affiliation":[{"name":"Pediatric Surgery Department, Penteli\u2019s Children Hospital, 15236 Penteli, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Doganis","sequence":"additional","affiliation":[{"name":"Department of Paediatric Oncology, P.&A. Kyriakou Children\u2019s Hospital, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2949-5254","authenticated-orcid":false,"given":"Sophia","family":"Pasparaki","sequence":"additional","affiliation":[{"name":"Second Department of Paediatrics, School of Medicine, National and Kapodistrian University of Athens (NKUA), P.&A. Kyriakou Children\u2019s Hospital, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0476-6586","authenticated-orcid":false,"given":"Lydia","family":"Kossiva","sequence":"additional","affiliation":[{"name":"Second Department of Paediatrics, School of Medicine, National and Kapodistrian University of Athens (NKUA), P.&A. Kyriakou Children\u2019s Hospital, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6075-3002","authenticated-orcid":false,"given":"Vassiliki","family":"Papaevangelou","sequence":"additional","affiliation":[{"name":"Third Department of Paediatrics, School of Medicine, National and Kapodistrian University of Athens (NKUA), Attikon Hospital, 12462 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2485-4409","authenticated-orcid":false,"given":"Maria","family":"Tsolia","sequence":"additional","affiliation":[{"name":"Second Department of Paediatrics, School of Medicine, National and Kapodistrian University of Athens (NKUA), P.&A. Kyriakou Children\u2019s Hospital, 11527 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,2]]},"reference":[{"key":"ref_1","first-page":"273","article-title":"Febrile Neutropenia in Cancer Patient: Epidemiology, Microbiology, Pathophysiology and Management","volume":"5","author":"Rasmy","year":"2016","journal-title":"JCPCR"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"v111","DOI":"10.1093\/annonc\/mdw325","article-title":"Management of Febrile Neutropaenia: ESMO Clinical Practice Guidelines","volume":"27","author":"Klastersky","year":"2016","journal-title":"Ann. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jpeds.2018.06.056","article-title":"National Trends in Hospitalization for Fever and Neutropenia in Children with Cancer, 2007\u20132014","volume":"202","author":"Lekshminarayanan","year":"2018","journal-title":"J. Pediatr."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Mueller, E.L., Walkovich, K.J., Mody, R., Gebremariam, A., and Davis, M.M. (2015). Hospital Discharges for Fever and Neutropenia in Pediatric Cancer Patients: United States, 2009. BMC Cancer, 15.","DOI":"10.1186\/s12885-015-1413-8"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/08880018.2015.1102998","article-title":"Fever and Neutropenia Hospital Discharges in Children with Cancer: A 2012 Update","volume":"33","author":"Mueller","year":"2016","journal-title":"Pediatr. Hematol. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e552","DOI":"10.1200\/JOP.2016.019588","article-title":"Cost of Cancer-Related Neutropenia or Fever Hospitalizations, United States, 2012","volume":"13","author":"Tai","year":"2017","journal-title":"JOP"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1097\/CCM.0000000000001142","article-title":"The Impact of Timing of Antibiotics on Outcomes in Severe Sepsis and Septic Shock: A Systematic Review and Meta-Analysis","volume":"43","author":"Sterling","year":"2015","journal-title":"Crit. Care Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","article-title":"Duration of Hypotension before Initiation of Effective Antimicrobial Therapy Is the Critical Determinant of Survival in Human Septic Shock","volume":"34","author":"Kumar","year":"2006","journal-title":"Crit. Care Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13643-019-1006-8","article-title":"Protocol for a Systematic Review of Time to Antibiotics (TTA) in Patients with Fever and Neutropenia during Chemotherapy for Cancer (FN) and Interventions Aiming to Reduce TTA","volume":"8","author":"Koenig","year":"2019","journal-title":"Syst. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00043426-199511000-00008","article-title":"Cessation of Antibiotics Regardless of ANC Is Safe in Children with Febrile Neutropenia. A Preliminary Prospective Trial","volume":"17","author":"Cohen","year":"1995","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0022-3476(81)80694-4","article-title":"Infectious Complications in the Child with Cancer. I. Pathophysiology of the Compromised Host and the Initial. Evaluation and Management of the Febrile Cancer Patient","volume":"98","author":"Pizzo","year":"1981","journal-title":"J. Pediatr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/infdis\/161.3.381","article-title":"From the Infectious Diseases Society of America. Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever","volume":"161","author":"Hughes","year":"1990","journal-title":"J. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3892\/mco.2016.957","article-title":"Chemotherapy-Induced Neutropenia among Pediatric Cancer Patients in Egypt: Risks and Consequences","volume":"5","author":"Badr","year":"2016","journal-title":"Mol. Clin. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e020324","DOI":"10.1136\/bmjopen-2017-020324","article-title":"Quest for Certainty Regarding Early Discharge in Paediatric Low-Risk Febrile Neutropenia: A Multicentre Qualitative Focus Group Discussion Study Involving Patients, Parents and Healthcare Professionals in the UK","volume":"8","author":"Morgan","year":"2018","journal-title":"BMJ Open"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1200\/JCO.22.02224","article-title":"Guideline for the Management of Fever and Neutropenia in Pediatric Patients with Cancer and Hematopoietic Cell Transplantation Recipients: 2023 Update","volume":"41","author":"Lehrnbecher","year":"2023","journal-title":"JCO"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1200\/JCO.1990.8.12.1998","article-title":"Early Hospital Discharge of Children with Cancer Treated for Fever and Neutropenia: Identification and Management of the Low-Risk Patient","volume":"8","author":"Mullen","year":"1990","journal-title":"J. Clin. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0022-3476(05)82536-3","article-title":"Hematologic Predictors of Bone Marrow Recovery in Neutropenic Patients Hospitalized for Fever: Implications for Discontinuation of Antibiotics and Early Discharge from the Hospital","volume":"121","author":"Griffin","year":"1992","journal-title":"J. Pediatr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/1097-0142(19940701)74:1<189::AID-CNCR2820740130>3.0.CO;2-7","article-title":"Safety and Cost Effectiveness of Early Hospital Discharge of Lower Risk Children with Cancer Admitted for Fever and Neutropenia","volume":"74","author":"Bash","year":"1994","journal-title":"Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0022-3476(05)81358-7","article-title":"Risk Factors for Recurrent Fever after the Discontinuation of Empiric Antibiotic Therapy for Fever and Neutropenia in Pediatric Patients with a Malignancy or Hematologic Condition","volume":"124","author":"Jones","year":"1994","journal-title":"J. Pediatr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3109\/08880019409140541","article-title":"Early Discharge of Pediatric Febrile Neutropenic Cancer Patients by Substitution of Oral for Intravenous Antibiotics","volume":"11","author":"Lau","year":"1994","journal-title":"Pediatr. Hematol. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/(SICI)1096-911X(199703)28:3<191::AID-MPO7>3.0.CO;2-E","article-title":"Safety of Early Hospital Discharge of Selected Febrile Children and Adolescents with Cancer with Prolonged Neutropenia","volume":"28","author":"Aquino","year":"1997","journal-title":"Med. Pediatr. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1086\/514512","article-title":"Early Discharge of Low-Risk Febrile Neutropenic Children and Adolescents with Cancer","volume":"25","author":"Aquino","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1086\/317552","article-title":"Oral Cefixime Is Similar to Continued Intravenous Antibiotics in the Empirical Treatment of Febrile Neutropenic Children with Cancer","volume":"32","author":"Shenep","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s15010-002-2094-1","article-title":"Short Courses of Intravenous Empirical Antibiotic Treatment in Selected Febrile Neutropenic Children with Cancer","volume":"30","author":"Lehrnbecher","year":"2002","journal-title":"Infection"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/mpo.10208","article-title":"Ciprofloxacin and Amoxicillin as Continuation Treatment of Febrile Neutropenia in Pediatric Cancer Patients","volume":"40","author":"Park","year":"2003","journal-title":"Med. Pediatr. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/cncr.11251","article-title":"Outpatient, Sequential, Parenteral-oral Antibiotic Therapy for Lower Risk Febrile Neutropenia in Children with Malignant Disease: A Single-center, Randomized, Controlled Trial in Argentina","volume":"97","author":"Paganini","year":"2003","journal-title":"Cancer"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1200\/JCO.2004.01.078","article-title":"Early Hospital Discharge Followed by Outpatient Management Versus Continued Hospitalization of Children with Cancer, Fever, and Neutropenia at Low Risk for Invasive Bacterial Infection","volume":"22","author":"Santolaya","year":"2004","journal-title":"JCO"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Hodgson-Viden, H., Grundy, P.E., and Robinson, J.L. (2005). Early Discontinuation of Intravenous Antimicrobial Therapy in Pediatric Oncology Patients with Febrile Neutropenia. BMC Pediatr., 5.","DOI":"10.1186\/1471-2431-5-10"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/pbc.21179","article-title":"Early Hospital Discharge versus Continued Hospitalization in Febrile Pediatric Cancer Patients with Prolonged Neutropenia: A Randomized, Prospective Study","volume":"49","author":"Ahmed","year":"2007","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/pbc.24076","article-title":"First-day Step-down to Oral Outpatient Treatment versus Continued Standard Treatment in Children with Cancer and Low-risk Fever in Neutropenia. A Randomized Controlled Trial within the Multicenter SPOG 2003 FN Study","volume":"59","author":"Brack","year":"2012","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejca.2015.10.065","article-title":"Risk-Adapted Approach for Fever and Neutropenia in Paediatric Cancer Patients\u2014A National Multicentre Study","volume":"53","author":"Miedema","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/pbc.26072","article-title":"Early Discharge of Neutropenic Pediatric Oncology Patients Admitted with Fever","volume":"63","author":"Villanueva","year":"2016","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e26875","DOI":"10.1002\/pbc.26875","article-title":"Safety of Discharge for Children with Cancer and Febrile Neutropenia off Antibiotics Using Absolute Neutrophil Count Threshold Values as a Surrogate Marker for Adequate Bone Marrow Recovery","volume":"65","author":"Campbell","year":"2018","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_35","first-page":"1135","article-title":"Early discharge of pediatric patients with cancer, fever, and neutropenia with low-risk of systemic infection","volume":"75","year":"2019","journal-title":"BMHIM"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.jmii.2020.07.014","article-title":"Analysis of Antibiotics Discontinuation during Bone Marrow Suppression in Childhood, Adolescent and Young Adult Patients with Febrile Neutropenia","volume":"54","author":"Kobayashi","year":"2021","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/archdischild-2019-317908","article-title":"Short-Course Antibiotics for Chemotherapy-Induced Febrile Neutropaenia: Retrospective Cohort Study","volume":"105","author":"Seneviratne","year":"2020","journal-title":"Arch. Dis. Child."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e880","DOI":"10.1097\/MPH.0000000000002074","article-title":"Assessing Safe Discharge Criteria for Pediatric Oncology Patients Admitted for Febrile Neutropenia","volume":"43","author":"Huschart","year":"2021","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12098-020-03377-x","article-title":"Early Discontinuation versus Continuation of Antimicrobial Therapy in Low Risk Pediatric Cancer Patients with Febrile Neutropenia, Before Recovery of Counts: A Randomized Controlled Trial (DALFEN Study)","volume":"88","author":"Kumar","year":"2021","journal-title":"Indian J. Pediatr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1055\/s-0042-1745834","article-title":"Once-a-Day Ceftriaxone-Amikacin Combination as Empiric Antibiotic Therapy to Enable Outpatient Management of Febrile Neutropenia in Children-16-Year Experience from a Single Institute","volume":"11","author":"Kanvinde","year":"2022","journal-title":"South Asian J. Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e948","DOI":"10.1097\/MPH.0000000000002757","article-title":"Outcomes of Children Discharged Prior to Absolute Neutrophil Count Recovery After Admission for Febrile Neutropenia","volume":"45","author":"Peters","year":"2023","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/08880018.2023.2249940","article-title":"Safety of Procalcitonin Guided Early Discontinuation of Antibiotic Therapy among Children Receiving Cancer Chemotherapy and Having Low-Risk Febrile Neutropenia: A Randomized Feasibility Trial (ProFenC Study)","volume":"41","author":"Srinivasan","year":"2024","journal-title":"Pediatr. Hematol. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/archdischild-2021-323254","article-title":"Can I Go Home Now? The Safety and Efficacy of a New UK Paediatric Febrile Neutropenia Protocol for Risk-Stratified Early Discharge on Oral Antibiotics","volume":"108","author":"Jackson","year":"2023","journal-title":"Arch. Dis. Child."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"106171","DOI":"10.1016\/j.jinf.2024.106171","article-title":"Safety of Empirical Antibiotic Therapy Discontinuing for Fever of Unknown Origin during High-Risk Neutropenia in Children","volume":"88","author":"Maud","year":"2024","journal-title":"J. Infect."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e249","DOI":"10.1097\/MPH.0000000000003076","article-title":"Early Versus Late Discontinuation of Empirical Antibiotics in Pediatric Oncology Patients with Fever and Neutropenia","volume":"47","author":"Asleh","year":"2025","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"100321","DOI":"10.1016\/j.ejcped.2025.100321","article-title":"Early Discontinuation of Empiric Antibiotic Therapy in Children Treated for Cancer Who Develop Febrile Neutropenia: A Prospective Cohort Study","volume":"6","author":"Papachristidou","year":"2025","journal-title":"EJC Paediatr. Oncol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/1\/103\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T09:51:21Z","timestamp":1767347481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/1\/103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,2]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["medicina62010103"],"URL":"https:\/\/doi.org\/10.3390\/medicina62010103","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,2]]}}}